Tag: Fidaxomicin

As the leading cause of healthcare-associated infectious diarrhea in the United States, *Clostridioides difficile* (*C. diff*) requires specific, targeted antibiotic therapy to address the infection. While paradoxically caused by antibiotic use, the primary treatment for an active *C. diff* infection is a narrow-spectrum antibiotic that kills *C. diff* without causing further disruption to the gut microbiome.

According to the CDC, about 500,000 *C. diff* infections occur in the United States each year, most commonly linked to antibiotic use. Knowing what antibiotic is used to get rid of C. diff is vital, with modern guidelines prioritizing highly effective drugs like fidaxomicin and oral vancomycin.